Organigram Holdings Inc. EPS (Diluted, from Cont. Ops)

EPS (Diluted, from Cont. Ops) of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Diluted, from Cont. Ops) growth rates and interactive chart.


Highlights and Quick Summary

  • EPS (Diluted, from Cont. Ops) for the quarter ending August 31, 2022 was $-0.0156 (a 119.72% increase compared to previous quarter)
  • Year-over-year quarterly EPS (Diluted, from Cont. Ops) increased by 358.82%
  • Annual EPS (Diluted, from Cont. Ops) for 2022 was $-0.0364 (a -90.55% decrease from previous year)
  • Annual EPS (Diluted, from Cont. Ops) for 2021 was $-0.385 (a -32.26% decrease from previous year)
  • Annual EPS (Diluted, from Cont. Ops) for 2020 was $-0.569 (a 1102.54% increase from previous year)
  • Twelve month EPS (Diluted, from Cont. Ops) ending August 31, 2022 was $-0.0364 (a -31.96% decrease compared to previous quarter)
  • Twelve month trailing EPS (Diluted, from Cont. Ops) decreased by -86.02% year-over-year
Trailing EPS (Diluted, from Cont. Ops) for the last four month:
31 Aug '22 31 May '22 28 Feb '22 30 Nov '21
$-0.0364 $-0.0535 $-0.057 $-0.26
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Diluted, from Cont. Ops) of Organigram Holdings Inc.

Most recent EPS (Diluted, from Cont. Ops)of OGI including historical data for past 10 years.

Interactive Chart of EPS (Diluted, from Cont. Ops) of Organigram Holdings Inc.

Organigram Holdings Inc. EPS (Diluted, from Cont. Ops) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.0 $0.0 $0.0 $0.0
2021 $0.0 $0.0 $0.0 $0.0 $0.0
2020 $0.0 $0.0 $0.0 $0.0 $0.0
2019 $0.0 $0.0 $0.0 $0.0 $0.0
2018 $0.0 $0.0 $0.0

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic